Trial Profile
Examination of utility of bisphosphonate to osteoporosis by ovarian insufficiency after gynecologic cancer treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 May 2015
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary)
- Indications Bone resorption; Osteoporosis
- Focus Therapeutic Use
- 28 May 2015 Status changed from not yet recruiting to completed as per University Hospital Medical Information Network - Japan.
- 03 Jun 2011 New trial record